Figure 4
Difference of frequency of vomiting and erythema adverse events depending on COMT and OPRM1 gene variants in oxycodone/naloxone case groups.
Figure 4 | Scientific Reports
Difference of frequency of vomiting and erythema adverse events depending on COMT and OPRM1 gene variants in oxycodone/naloxone case groups.
